Latest News and Press Releases
Want to stay updated on the latest news?
-
- Company reports 20-fold expansion of commercial footprint, 33-fold increase in EEG/ERP brain scan volumes - - Harnessing increased data and cutting-edge supercomputing potentially unlocks new...
-
Fast Company and Texas A&M to Host ‘In Good Company’ Special Event During SXSW 2026 convening top leaders from Roku, NASA, The Farmer’s Dog, and more.
-
20,797 vehicles were delivered in February 2026, increasing by 57.6% year-over-year47,979 vehicles were delivered year-to-date in 2026, increasing by 77.3% year-over-yearCumulative deliveries reached...
-
S'il est approuvé, Ojemda® (tovorafénib) devrait devenir la première et la seule thérapie ciblée dans l’Union européennepour les enfants atteints d’un gliome pédiatrique de bas grade en rechute ou...
-
If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or refractory BRAF-altered pediatric low-grade glioma,...
-
SHANGHAI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today...
-
SHANGHAI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today...
-
Day One reports fourth quarter and full year 2025 financial results and reaffirms 2026 outlook and revenue guidance
-
Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Cannabis Vaporizers Market Report 2026" has been added to ResearchAndMarkets.com's offering. The cannabis vaporizers market has witnessed rapid...
-
FY 2025 sales growth of 10.9% at CER1, or 8.1% as reported, driven by growth of the three therapeutic areas of Oncology (4.1%1), Rare Disease (102.5%1) and Neuroscience (9.7%1); Somatuline® sales...